| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.RADONC.2013.06.032 |
| P698 | PubMed publication ID | 23932154 |
| P50 | author | Frank Kramer | Q83175542 |
| Matthias Dobbelstein | Q38322479 | ||
| P2093 | author name string | Xin Zhang | |
| Jochen Gaedcke | |||
| Michael Ghadimi | |||
| Hendrik A Wolff | |||
| Peter Jo | |||
| Tim Beißbarth | |||
| Melanie Spitzner | |||
| Marian Grade | |||
| Julia Kitz | |||
| Silke Kaulfuß | |||
| Junius Salendo | |||
| P4510 | describes a project that uses | LS411N | Q54903069 |
| LS513 | Q54903070 | ||
| SW1116 | Q54971073 | ||
| SW1463 | Q54971083 | ||
| SW403 | Q54971109 | ||
| SW837 | Q54971210 | ||
| WiDr | Q54994056 | ||
| Caco-2 | Q5016050 | ||
| HT-29 | Q28334700 | ||
| SW480 | Q28472974 | ||
| SW620 | Q28519412 | ||
| LS1034 | Q54903040 | ||
| P433 | issue | 3 | |
| P921 | main subject | microRNA expression | Q60681249 |
| colorectal cancer | Q188874 | ||
| cell line | Q21014462 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 451-457 | |
| P577 | publication date | 2013-08-07 | |
| P1433 | published in | Radiotherapy and Oncology | Q14251029 |
| P1476 | title | Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g | |
| P478 | volume | 108 |
| Q55260348 | A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer. |
| Q34103984 | A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway |
| Q27024427 | An update on microRNAs as colorectal cancer biomarkers: where are we and what's next? |
| Q33838484 | Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy. |
| Q34654543 | Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions |
| Q37665639 | Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer |
| Q36849645 | Colorectal cancer carcinogenesis: a review of mechanisms |
| Q33875392 | Comparative transcriptome analysis reveals significant differences in MicroRNA expression and their target genes between adipose and muscular tissues in cattle |
| Q89619336 | Cross-Resistance of Acquired Radioresistant Colorectal Cancer Cell Line to gefitinib and regorafenib |
| Q33689077 | Development of a radiosensitivity gene signature for patients with soft tissue sarcoma |
| Q37288584 | Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma. |
| Q58608524 | Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma |
| Q37709253 | Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network |
| Q38826542 | Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer. |
| Q42365277 | Knockdown of MALAT1 expression inhibits HUVEC proliferation by upregulation of miR-320a and downregulation of FOXM1 expression |
| Q50469164 | MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors. |
| Q26748754 | MicroRNA in rectal cancer |
| Q89739864 | MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element-binding protein 1 |
| Q39390383 | MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy |
| Q26751780 | MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer |
| Q26775610 | MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer |
| Q38247982 | MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. |
| Q90429127 | MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside |
| Q39438832 | Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer |
| Q57739115 | Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives |
| Q47761940 | Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature. |
| Q36847230 | Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer |
| Q55307845 | Prognostic value of microRNAs in colorectal cancer: a meta-analysis. |
| Q36140693 | Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb |
| Q91707587 | Specific miRNA expression profile in the blood serum of cardiac myxoma patients |
| Q36090214 | The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis |
| Q34273062 | The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer |
| Q38802458 | Understanding the CREB1-miRNA feedback loop in human malignancies |
| Q58617961 | miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer |
| Q33967807 | miR-320a is an independent prognostic biomarker for invasive breast cancer |
| Q90445974 | miR-361 enhances sensitivity to 5-fluorouracil by targeting the FOXM1-ABCC5/10 signaling pathway in colorectal cancer |
Search more.